Development of a radioimmunoassay for measuring gonadotrophin releasing hormone in patients receiving treatment.
A radioimmunoassay for the measurement of gonadotrophin releasing hormone (GnRH) in plasma and urine using readily available reagents was developed. The GnRH assay showed good precision, recovery, and parallelism over a wide range of GnRH concentrations with a sensitivity of 15 pg/ml. The assay was compared with a commercially available kit (Buhlmann Laboratories). Although the Buhlmann kit showed acceptable precision, recovery, sensitivity, and correlation with the developed GnRH assay for plasma samples, lack of parallelism of serially diluted plasma and urine samples was consistently observed, together with a poor correlation with the developed GnRH assay for urine, suggesting a matrix effect with the Buhlmann kit. The developed assay is suitable for measuring GnRH in samples obtained from patients receiving pulsatile infusions of GnRH. In contrast, the commercially available Buhlmann kit was unsuitable for measuring plasma GnRH as the kit had a top standard of only 160 pg/ml, well below the peak plasma concentration. It would not be possible to dilute samples for analysis because of the lack of parallelism of diluted samples compared with standards obtained with the Buhlmann assay.
Mosby
V A
VA
Department of Chemical Pathology, Charing Cross and Westminster Medical School, Westminster Hospital, London.
Knapp
M L
ML
Fink
R S
RS
Osgood
V M
VM
Mayne
P D
PD
D005260:Female; D006801:Humans; D007247:Infertility, Female / Q000097:blood / Q000378:metabolism; D010906:Pituitary Hormone-Releasing Hormones / Q000032:analysis* / Q000097:blood / Q000652:urine; D011863:Radioimmunoassay / Q000379:methods*; D011933:Reagent Kits, Diagnostic
D010906:Pituitary Hormone-Releasing Hormones; D011933:Reagent Kits, Diagnostic